Alicia Schiffrin

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections

Alicia Schiffrin, Mimi M Belmonte · Diabetes Care · 1982 · 198 citations

Long-term Glucose Control, Metabolic Syndrome, Diabetes Management +11

Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Injections of Insulin: A One-Year Prospective Study

Alicia Schiffrin, Mimi M Belmonte · Diabetes · 1982 · 170 citations

Hyperglycemia After Intense Exercise in IDDM Subjects During Continuous Subcutaneous Insulin Infusion

Teresa H Mitchell, Gebrehiwot Abraham, Alicia Schiffrin et al. · Diabetes Care · 1988 · 117 citations

Physical Activity, Same Intense Exercise, Iddm Subjects +17